公司公告汇总：京粮控股因2023年部分贸易无商业实质被证监会采取责令改正措施，涉及收入金 额298,629,084.17元。 公司公告汇总：公司董事会换届选举工作延期，原定任期于2025年9月26日届满。 海南京粮控股股份有限公司于2025年9月26日收到中国证券监督管理委员会海南监管局《关于对海南京 粮控股股份有限公司采取责令改正措施的决定》（〔2025〕32号）。经查，公司子公司2023年开展的部 分棕榈油、花生油、花生米、大豆贸易无商业实质或收入确认不符合会计准则，涉及收入金额 298,629,084.17元，占2023年经审计营业收入的2.51%，违反《上市公司信息披露管理办法》第三条第一 款规定。海南证监局决定对公司采取责令改正措施，并记入资本市场诚信档案数据库。公司需在收到决 定书之日起30日内提交书面整改报告。公司表示高度重视，将认真整改，本次监管措施不影响正常生产 经营。 海南京粮控股股份有限公司第十届董事会、监事会原定于2025年9月26日任期届满。由于换届选举、配 套管理制度修订及监事会改革等相关工作仍在筹备中，为保障治理连续性与稳定性，董事会、监事会及 高级管理人员任期相应顺延。在新一届 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 如果对本监督管理措施不服，可以在收到本决定书之日起60日内向中国证券监督管理委员会提出行政复 议申请，也可以在收到本决定书之日起6个月内向有管辖权的人民法院提起诉讼。复议与诉讼期间，上 述监督管理措施不停止执行。 二、相关说明 公司高度重视《决定书》中指出的问题，按照相关法律法规要求认真总结、整改。本次行政监管措施不 会影响公司正常的生产经营活动，公司将继续努力做好经营管理和规范治理工作。敬请广大投资者理性 投资，注意投资风险。 特此公告。 海南京粮控股股份有限公司 海南京粮控股股份有限公司（以下简称"公司 "）于2025年9月26日收到中国证券监督管理委员会海南监 管局（以下简称"海南证监局"）出具的《关于对海南京粮控股股份有限公司采取责令改正措施的决定》 （〔2025〕32号）（以下简称"《决定书》"。现将相关情况公告如下： 一、决定书主要内容 海南京粮控股股份有限公司： 经查，我局发现你公司存在以下问题： 2023年，你公司子公司开展的部分棕榈油、花生油、花 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 海南京粮控股股份有限公司（以下简称"公司"）第十届董事会、监事会于2025年9月26日任期届满。鉴 于公司换届选举、配套管理制度修订以及监事会改革等相关工作正在筹备中，为保证公司董事会、监事 会工作的连续性及稳定性，公司董事会换届选举工作将适当延期，公司董事会、董事会各专门委员会、 高级管理人员的任期相应顺延，监事会任期亦相应顺延。 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：000505 200505 证券简称：京粮控股 京粮B 公告编号：2025-043 海南京粮控股股份有限公司 关于董事会延期换届的提示性公告 2025年9月27日 在新一届董事会换届选举及监事会改革完成前，公司第十届董事会成员、监事会成员、董事会各专门委 员会成员及高级管理人员将依照法律法规和《公司章程》等相关规定继续履行相应的职责和义务。公司 延期换届不会影响公司的正常生产经营，公司将积极推进董事会换届、监事会改革等工作，并按照相关 规定及时履行信息披露义务。 特此公告。 董 事 会 海南京粮控股股份有限公司 ...

Group 1 - Baiyun Airport announces joint investment with China Duty Free Group to establish a duty-free company with a registered capital of 45 million yuan, where China Duty Free Group holds 51% [3] - Dongxing Medical plans to acquire 90% stake in Wuhan Yijiaobao, a high-tech company focused on orthopedic and biomedical materials [4] - Fosun Pharma's subsidiary plans to transfer 100% stake in Shanghai Clone to enhance asset operation efficiency, with a transaction value of up to 1.256 billion yuan [5] Group 2 - Hengxing Technology's subsidiary is awaiting approval for the extension of mining license for Longtoushan Gold Mine, with exploration activities ongoing [6] - New Sai Co. announces resignation of its general manager Chen Jianjiang due to work adjustments [7] - Hailiang Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange, with details yet to be finalized [8] Group 3 - Zhejiang University Network plans to sell 48.6 million shares of Wanliyang, expecting a transaction amount of 475 million yuan [9] - Huazhong Precision terminates the issuance of A-shares to specific targets, affecting a control acquisition [10] - Jiaze New Energy states that its green chemical business is not yet commercially viable, with no significant impact on revenue or profit in the short term [11] Group 4 - Hailan Home plans to issue H-shares and list on the Hong Kong Stock Exchange, with discussions ongoing with intermediaries [12] - Hongfuhang intends to invest up to 1.128 billion yuan in a joint venture to build a photovoltaic energy storage project in Congo [13] - Zhongchuang Zhiling plans to invest 5 billion yuan in a new energy vehicle parts industrial base and R&D center [14] Group 5 - Haitai Development's subsidiary signs a property sale contract worth 440 million yuan, expected to increase profits by approximately 62.86 million yuan in 2025 [15] - Dongjie Intelligent's overseas subsidiary secures a procurement order worth approximately 180 million yuan, representing 22.3% of its audited revenue for 2024 [17] - Zhiguang Electric's subsidiary signs a procurement contract worth 164 million yuan for energy storage systems [18] Group 6 - ST Songfa's subsidiary signs a shipbuilding contract for four VLCCs, with a contract value between 400 million to 600 million USD [19] - Huaguang Huaneng signs a sales contract for waste heat boilers worth 160 million yuan for a power plant project in Cambodia [20] - Yousheng Co. receives a project notification from a German automaker, with total sales expected to reach approximately 2.3 billion yuan [24] Group 7 - Zai Sheng Technology's controlling shareholder plans to reduce holdings by up to 3% [25] - Compton plans to reduce holdings of repurchased shares by up to 1% [26] - Aored plans to reduce holdings of repurchased shares by up to 1.29% [27] Group 8 - Xianhe Co. plans to raise up to 3 billion yuan through a private placement for a new materials project [34] - Guanshi Technology plans to raise up to 700 million yuan for photomask manufacturing and other projects [33] - Beilu Pharmaceutical plans to raise up to 300 million yuan for production facility upgrades and working capital [34]

证券日报网讯 9月26日晚间，京粮控股发布公告称，海南京粮控股股份有限公司（以下简称"公司"）第 十届董事会、监事会于2025年9月26日任期届满。鉴于公司换届选举、配套管理制度修订以及监事会改 革等相关工作正在筹备中，为保证公司董事会、监事会工作的连续性及稳定性，公司董事会换届选举工 作将适当延期，公司董事会、董事会各专门委员会、高级管理人员的任期相应顺延，监事会任期亦相应 顺延。 （编辑 楚丽君） ...

Major Events - Baiyun Airport announced a joint investment with China Duty Free Group to establish a duty-free company at Guangzhou Baiyun Airport with a registered capital of 45 million yuan, where China Duty Free will contribute 22.95 million yuan for a 51% stake [4] - Dongxing Medical plans to acquire 90% of Wuhan Yijiaobao's equity for cash, which is expected to constitute a major asset restructuring [5] - Fosun Pharma's subsidiary is planning to transfer 100% of Shanghai Clon to enhance asset operation efficiency, with a transaction value of up to 1.256 billion yuan [7] - Hengxing Technology's subsidiary is undergoing a review for the extension of mining license for Longtoushan Gold Mine, with exploration activities ongoing [8] - New Sai Co.'s general manager Chen Jianjiang resigned due to work adjustments [9] - Hailiang Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange, with details yet to be finalized [10] - Zhejiang University Net announced plans to sell 48.6 million shares of Wanliyang, expecting a transaction amount of 475 million yuan [11] - Huazhong Precision terminated its plan to issue A-shares to specific investors, which also halts the acquisition of control by a third party [12] - Jiazhe New Energy stated that its green chemical business is not yet commercially viable [13] Significant Contracts - Haitai Development's subsidiary signed a property sale contract worth 440 million yuan, expected to increase profits by approximately 62.86 million yuan in 2025 [18] - Dongjie Intelligent's overseas subsidiary received a procurement order worth approximately 180 million yuan, accounting for 22.3% of the company's audited revenue for 2024 [19][20] - Zhiguang Electric's subsidiary signed a procurement contract worth 164 million yuan for energy storage systems [21] - ST Songfa's subsidiary signed contracts for building four oil tankers, with a total value between 400 million to 600 million USD [22] - Huaguang Huaneng signed a sales contract for waste heat boilers worth 160 million yuan for a power plant project in Cambodia [23] - Keda Intelligent plans to issue H-shares and list on the Hong Kong Stock Exchange, with details still under discussion [24] Shareholding Changes - Zai Sheng Technology's controlling shareholder plans to reduce holdings by up to 3% [28] - Compton plans to reduce up to 1% of its repurchased shares [29] - Aorede plans to reduce up to 1.29% of its shares from the repurchased stock [30] - Yidian Tianxia's controlling shareholder plans to reduce up to 3% of its shares [31] - Huace Film's shareholders plan to transfer 3.6% of the company's shares through an inquiry transfer [32] Buybacks and Financing - Qibin Group obtained a special financing support of up to 90 million yuan for share repurchase [33] - CanSino plans to cancel 406,100 repurchased shares and reduce registered capital accordingly [35] Fundraising Initiatives - Xianhe Co. plans to raise up to 3 billion yuan through a private placement for a high-performance paper-based new materials project [36] - Guanshi Technology plans to raise up to 700 million yuan for photomask manufacturing and other projects [37] - Beilu Pharmaceutical plans to raise up to 300 million yuan for production line upgrades and working capital [38]

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 证券代码：000505 200505 证券简称：京粮控股 京粮 B 公告编号：2025-043 海南京粮控股股份有限公司 关于董事会延期换届的提示性公告 海南京粮控股股份有限公司 董 事 会 2025 年 9 月 27 日 1 海南京粮控股股份有限公司（以下简称"公司"）第十届董事会、监事会于 2025 年 9 月 26 日任期届满。鉴于公司换届选举、配套管理制度修订以及监事会改革等相关 工作正在筹备中，为保证公司董事会、监事会工作的连续性及稳定性，公司董事会换届 选举工作将适当延期，公司董事会、董事会各专门委员会、高级管理人员的任期相应顺 延，监事会任期亦相应顺延。 在新一届董事会换届选举及监事会改革完成前，公司第十届董事会成员、监事会成 员、董事会各专门委员会成员及高级管理人员将依照法律法规和《公司章程》等相关规 定继续履行相应的职责和义务。公司延期换届不会影响公司的正常生产经营，公司将积 极推进董事会换届、监事会改革等工作，并按照相关规定及时履行信息披露义务。 特此公告。 ...

债券代码：148434.SZ 债券简称：23京粮01 中德证券有限责任公司（简称"中德证券"）编制本报告涉及的内容及信息 来源于发行人公开信息披露文件、发行人向中德证券提供的支撑性相关文件。 本报告不构成对投资者进行或不进行某项行为的推荐意见，投资者应对相关 事宜做出独立判断，而不应将本报告中的任何内容据以作为中德证券所作的承诺 或声明。在任何情况下，投资者依据本报告所进行的任何作为或不作为，中德证 券不承担任何责任。在任何情况下，未经中德证券书面许可，不得将本报告用作 其他任何用途。 2 中德证券有限责任公司 关于海南京粮控股股份有限公司 收到中国证券监督管理委员会海南监 管局行政监管措施决定书 之临时受托管理事务报告 债券受托管理人 （北京市朝阳区建国路81号华贸中心1号写字楼22层） 2025年9月 重要声明 一、公司债券基本情况 8、兑付日：2026-08-22（如遇法定节假日或休息日，则顺延至其后的第1个 交易日，顺延期间不另计利息） 1、债券名称：海南京粮控股股份有限公司2023年面向专业投资者公开发行 公司债券（第一期） 9、信用评级：主体AA+/债项AAA 2、债券简称：23京粮01 3、债券 ...

Joint Ventures and Investments - Baiyun Airport announced a joint investment with China Duty Free Group to establish a duty-free company with a registered capital of 45 million yuan, where China Duty Free Group holds a 51% stake [3] - Dongxing Medical plans to acquire 90% of Wuhan Yijiaobao Biological Materials Co., a high-tech enterprise focused on orthopedic and biomedical materials [4] - Fosun Pharma's subsidiary is planning to transfer 100% of Shanghai Cloning's equity to enhance asset operation efficiency, with a transaction value of up to 1.256 billion yuan [5] Corporate Actions - New Sai Co. announced the resignation of its director and general manager, Chen Jianjiang, due to work adjustments [7] - Hailiang Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange, with discussions ongoing with intermediaries [8] - Zhejiang University Network New plans to sell 48.6 million shares of Wanliyang, expecting a transaction amount of 475 million yuan [9] Contracts and Orders - Haitai Development's subsidiary signed a property sale contract worth 440 million yuan, expected to increase the company's profit by approximately 62.86 million yuan in 2025 [12] - Dongjie Intelligent's overseas subsidiary received a procurement order worth approximately 180 million yuan, accounting for 22.3% of the company's audited revenue for 2024 [13] - Zhiguang Electric's subsidiary signed a procurement contract worth 164 million yuan for high-voltage energy storage systems [14] - ST Songfa's subsidiary signed contracts for the construction of four oil tankers, with a total contract value between 400 million to 600 million USD [15] - Huaguang Huaneng signed a sales contract for waste heat boilers worth 160 million yuan for a power plant project in Cambodia [16] Regulatory and Compliance - Jingliang Holdings received an administrative regulatory decision from Hainan Securities Regulatory Bureau for violations related to trade activities, involving an income amount of 299 million yuan [18] Shareholder Actions - Zaiseng Technology's controlling shareholder plans to reduce its stake by up to 3%, amounting to approximately 30.9 million shares [20] - Compton plans to reduce its repurchased shares by up to 1%, totaling approximately 2.5644 million shares [21] Financing Activities - Qibin Group obtained a special financing support of up to 90 million yuan for share repurchase from Industrial and Commercial Bank of China [23] - Xianhe Co. plans to raise up to 3 billion yuan through a private placement for a high-performance paper-based new materials project [25]

Group 1 - Dongxing Medical plans to acquire 90% equity of Wuhan Yijiaobao for cash, which is expected to constitute a major asset restructuring [1] - Fosun Pharma's subsidiary plans to transfer 100% equity of Shanghai Cloning, with a transaction value of up to 1.256 billion yuan [1] Group 2 - *ST Songfa's subsidiary signed a shipbuilding contract worth approximately 400-600 million USD for four VLCCs, expected delivery between late 2026 and mid-2027 [3] - Qibin Group obtained financing support of up to 90 million yuan for share repurchase [4] Group 3 - Shapuaisi's shareholder plans to reduce holdings by up to 3% of the company's total shares [5] - *ST Kaixin intends to use up to 310 million yuan for cash management in safe and liquid financial products [6] Group 4 - Junchen Technology's shareholders plan to transfer 2.5% of the company's shares due to personal funding needs [7] - Jingliang Holdings received an administrative regulatory measure from Hainan Securities Regulatory Bureau for improper revenue recognition involving 299 million yuan [7] Group 5 - Tongcheng Holdings received a cash dividend of 24.6643 million yuan from Changsha Bank [9] - Shenyang Chemical appointed Chen Liguo as the new general manager [10] Group 6 - Huaguang Huaneng signed a contract for a 160 million yuan waste heat boiler project [15] - Shuxian Valley's subsidiary completed the re-registration of a health food product [16] Group 7 - Xuanta Pharmaceutical's new specification for a diabetes treatment drug was approved [17] - Panlong Pharmaceutical's application for a pain relief gel patch was accepted by the drug regulatory authority [18] Group 8 - Zhiguang Electric's subsidiary won a procurement contract worth 164 million yuan for a storage system [19] - Chitianhua's production facility resumed operations after maintenance [20] Group 9 - Haitong Development's application for a specific A-share issuance was accepted by the Shanghai Stock Exchange, aiming to raise 210 million yuan [20] - Risheng Technology's shareholders plan to transfer 4.02% of the company's shares [33] Group 10 - Pingmei Shares' controlling shareholder plans a strategic restructuring with Henan Energy Group [35] - Shenghui Integration's controlling shareholder committed not to reduce shareholdings for 12 months [37] Group 11 - Agricultural Bank and Bank of China will no longer establish supervisory boards, with their functions transferred to the audit committees [39][40] - Dongfang Yuhong's subsidiary signed a contract for a seawater pipeline project worth 2.524 billion USD [40][41] Group 12 - Ganfeng Lithium plans to introduce investors for a capital increase of up to 2.5 billion yuan [50] - Hanyu Pharmaceutical intends to raise up to 968 million yuan for various projects [51]